Rappta Therapeutics
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.
Based based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), Rappta Therapeutics works in biopharma, biotechnology, life science, founded in 2006.
The company sits in the biopharma, biotechnology, life science segment, where it competes on its core product or service.
The company is recorded as being based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
The company is listed at the Series_A stage of development.
Its team size is recorded as c_00011_00050 employees.
Total disclosed funding stands at about $9M.
| Sector | Biopharma, Biotechnology, Life Science |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2006 |
| Employees | c_00011_00050 |
| Stage | series_a |
| Total funding | $9,000,000 |
Website: www.rappta-therapeutics.com
Sign in to view the contact information we hold for Rappta Therapeutics.
Create a free account
Create a free account